<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2019-23-3-70-77</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1698</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. CLINICAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Влияние комплексного санаторно-курортного лечения на уровень β2-микроглобулина сыворотки крови и мочи детей, больных хроническим пиелонефритом</article-title><trans-title-group xml:lang="en"><trans-title>The effect of complex sanatorium treatment on the level of β2-microglobulin serum and urine in children with chronic pyelonephritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Слободян</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Slobodian</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Слободян Елена Иркиновна - кандидат медицинских наук, доцент, кафедра педиатрии, физиотерапии и курортологии.</p><p>295600, Республика Крым, Симферополь, бульвар Ленина, д. 5/7, тел.: (36569) 33-571 - рабочий; (978) 820-18-97; факс: (36569) 36700</p></bio><bio xml:lang="en"><p>Helen I. Slobodian - MD, PhD, Associate professor, Department of рediatrics, physiotherapy and balneologia.</p><p>295600 Republic of Crimea, Simferopol, Lenin Blvd, 5/7, Phone: (36569) 33571 - office phone number; (978) 820-18-97</p></bio><email xlink:type="simple">elenaslobod@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каладзе</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaladze</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Каладзе Николай Николаевич - доктор медицинских наук, профессор, заведующий кафедрой педиатрии, физиотерапии и курортологии.</p><p>295600, Республика Крым, Симферополь, бульвар Ленина, д. 5/7, тел.: (36569) 33-571 - рабочий; факс: +736569-36700</p></bio><bio xml:lang="en"><p>Nikolai N. Kaladze - MD, PhD, DMedSci.,Professor, Department of рediatrics, physiotherapy and balneologia.</p><p>295600 Republic of Crimea, Simferopol, Lenin Blvd, 5/7, Phone (36569) 33-571</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Говдалюк</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Govdaliuk</surname><given-names>А. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Говдалюк Александр Леонидович - кандидат медицинских наук, кафедра анестезиологии-реаниматологии и скорой медицинской помощи.</p><p>295600, Республика Крым, Симферополь, бульвар Ленина, д. 5/7, тел.: (3652) 373-581 – рабочий</p></bio><bio xml:lang="en"><p>Alexander L. Govdalyuk - MD, PhD., Department of Anesthesiology, Intensive Care and Emergency Medical Care.</p><p>295600 Republic of Crimea, Simferopol, Lenin Blvd, 5/7, Phone: (3652) 373581</p></bio><email xlink:type="simple">simfi@yandex.ua</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Медицинская академия им. С.И. Георгиевского, Крымский федеральный университет им. В.И. Вернадского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Academy named after S.I. Georgievskogo; V.I. Vernadsky Crimean Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>23</day><month>03</month><year>2019</year></pub-date><volume>23</volume><issue>3</issue><fpage>70</fpage><lpage>77</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Слободян Е.И., Каладзе Н.Н., Говдалюк А.Л., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Слободян Е.И., Каладзе Н.Н., Говдалюк А.Л.</copyright-holder><copyright-holder xml:lang="en">Slobodian E.I., Kaladze N.N., Govdaliuk А.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1698">https://journal.nephrolog.ru/jour/article/view/1698</self-uri><abstract><sec><title>Цель</title><p>Цель: изучить влияние различных схем комплексного санаторно-курортного лечения на динамику β2-микроглобулина (β2-МГ) сыворотки крови и мочи у детей с различными клиническими формами хронического пиелонефрита (ХП).</p></sec><sec><title>Пациенты и методы</title><p>Пациенты и методы. В исследование включены 254 ребенка, больных ХП, в возрасте от 6 до 16 лет. У 205 (80,71 %) детей был диагностирован вторичный ХП, у 49 (19,29 %) детей - первичный ХП. Пациенты были рандомизированы в 5 групп: 1-я группа (n = 48) - группа сравнения. Их СКЛ включало санаторно-курортный режим, диету 5, лечебную гимнастику, климатотерапию, фитотерапию и бальнеотерапию. Пациенты всех последующих групп, помимо базисной терапии, получали пелоидотерапию. Дети 2-й группы (n = 56) - гальванопелоидотерапию области проекции почек, № 6; дети 3-й группы (n = 54) - амплипульспелоидотерапию области проекции почек, № 10; дети 4-й группы (n = 46) - грязевые аппликации на трусиковую зону, № 10; 5-й группы (n = 50) - грязевые аппликации на область проекции поясницы, № 8. Определяли β2 - МГ в сыворотке крови и моче с помощью стандартных наборов «DRG int., Inc», USA.</p></sec><sec><title>Результаты</title><p>Результаты. У больных с вторичным ХП до лечения диагностировано повышение β2-МГ в обеих биологических средах, у больных с первичным ХП - только в моче. На фоне комплексного санаторно-курортного лечения концентрация β2-МГ мочи у пациентов с первичным ХП была статистически значимо снижена во всех группах. Нормализованы - во 2-, 3-й и 5-й группах. Больные 2-й и 3-й групп имели значимое отличие от результата группы сравнения. У больных с вторичным ХП 3-й группы β2-МГ в обеих биологических средах достиг референсных показателей. В 4-й группе был нормализован в сыворотке крови и достоверно снижен в моче. В 1-, 2-й и 5-й группах достоверная динамика уровня β2-МГ мочи отсутствовала, а в сыворотке крови имела место только в 5-й группе.</p></sec><sec><title>Выводы</title><p>Выводы. Для нормализации β2-МГ сыворотки крови и мочи у больных с ХП целесообразно проведение пелоидотерапии. Площадь грязевого воздействия, длительность, сочетание с преформированным физическим фактором определяются индивидуально в зависимости от клинической формы ХП.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>The aim</title><p>The aim: to study the effect of various integrated spa treatment schemes on the β2-microglobulin (β2MG) dynamics of blood serum and urine in children with various clinical forms of chronic pyelonephritis (CP).</p></sec><sec><title>Patients and methods</title><p>Patients and methods. 254 children with CP, aged 6 to 16 years were included in the study. Secondary CP was diagnosed in 205 (80.71 %) children, primary CP was diagnosed in 49 (19.29 %) children. Patients were randomized into 5 groups: 1 group (n = 48) - comparison group. Spa treatment included a sanatorium-resort regimen, diet 5, physiotherapy, climatotherapy, phytotherapy and balneotherapy. Patients of all subsequent groups, in addition to basic therapy, received peloidotherapy. Children of the 2 group (n = 56) received 6 procedures of galvanopeloidotherapy on the projection area of the; children of 3 group (n = 54) - received 10 procedures of amplipulse peloid therapy on the projection area of the kidneys. Children of the 4 group children (n = 46) received 10 procedures of mud applications on the panty zone. Children of the 5 group 5 (n = 50) received 8 procedures of mud applications on the lumbar projection area. Determined p2-MG in serum and urine using standard sets "DRG int., Inc.", USA.</p></sec><sec><title>Results</title><p>Results. In patients with secondary CP before treatment, an increase in p2-MG in both biological media was diagnosed, in patients with primary CP, only in urine. On the background of a comprehensive spa treatment, the urine β2-MG concentration in patients with primary CP was statistically significantly reduced in all groups. Normalized - in 2, 3 and 5 groups. Patients of groups 2 and 3 had a significant difference from the result of the comparison group. In patients with secondary CP 3, the β2-MG group in both biological media reached reference values. In group 4, it was normalized in serum and significantly reduced in urine. In groups 1,2 and 5, there was no significant change in the level of urine β2-MG in urine, and in serum there was only in group 5.</p></sec><sec><title>Conclusion</title><p>Conclusion. For normalization of serum β2-MG and urine in patients with CP it is advisable to conduct peloidotherapy. The area of mud exposure, duration, combination with the preformed physical factor is determined individually, depending on the clinical form of CP.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>хронический пиелонефрит</kwd><kwd>β2-микроглобулин</kwd><kwd>санаторно-курортное лечение</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>chronic pyelonephritis</kwd><kwd>β2-microglobulin</kwd><kwd>spa treatment</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Argyropoulos C, Chen S, Ng Y et al. Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases. Frontiers in Medicine 2017; 4: 73. Doi: 10.3389/fmed.2017.00073</mixed-citation><mixed-citation xml:lang="en">Argyropoulos C, Chen S, Ng Y et al. Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases. Frontiers in Medicine 2017; 4: 73. Doi: 10.3389/fmed.2017.00073</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Joyce E, Glasner P, Ranganathan S, Swiatecka-Urban A. Tubulointerstitial nephritis: diagnosis, treatment, and monitoring. Pediatr Nephrol 2017; 32(4): 577-587. Doi: 10.1007/s00467-016-3394-5</mixed-citation><mixed-citation xml:lang="en">Joyce E, Glasner P, Ranganathan S, Swiatecka-Urban A. Tubulointerstitial nephritis: diagnosis, treatment, and monitoring. Pediatr Nephrol 2017; 32(4): 577-587. Doi: 10.1007/s00467-016-3394-5</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ikezumi X Uemura O, Nagai T et al. Beta-2 microglobulin-based equation for estimating glomerular filtration rates in Japanese children and adolescents. Clin Exp Nephrol 2015; 19(3):450-457. Doi: 10.1007/s10157-014-1015-9</mixed-citation><mixed-citation xml:lang="en">Ikezumi X Uemura O, Nagai T et al. Beta-2 microglobulin-based equation for estimating glomerular filtration rates in Japanese children and adolescents. Clin Exp Nephrol 2015; 19(3):450-457. Doi: 10.1007/s10157-014-1015-9</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Nielsen R, Christensen El, Birn H. Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease. Kidney Int 2016; 89(1):58-67. Doi: 10.1016/j.kint.2015.11.007</mixed-citation><mixed-citation xml:lang="en">Nielsen R, Christensen El, Birn H. Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease. Kidney Int 2016; 89(1):58-67. Doi: 10.1016/j.kint.2015.11.007</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">El-Frargy MS, El-Refaey AM, Eid R, Hussien MA. Serum cystatin-C and BETA 2-microglobulin as accurate markers in the early diagnosis of kidney injury in neonates: a single center study. Saudi J Kidney Dis Transpl 2015;26(4):712-717. Doi: 10.4103/1319-2442.160151</mixed-citation><mixed-citation xml:lang="en">El-Frargy MS, El-Refaey AM, Eid R, Hussien MA. Serum cystatin-C and BETA 2-microglobulin as accurate markers in the early diagnosis of kidney injury in neonates: a single center study. Saudi J Kidney Dis Transpl 2015;26(4):712-717. Doi: 10.4103/1319-2442.160151</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Тиктинский ОА, Александров ВП. Мочекаменная болезнь. Питер, СПб., 2000; 314-316</mixed-citation><mixed-citation xml:lang="en">Tiktinskii OA, Aleksandrov VP Urolithiasis disease. Piter, SPb., 2000; 314-316</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ravnskov U. Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism. Br J Clin Pharmacol 1999; 47(2):203-210. PMID: 10190656</mixed-citation><mixed-citation xml:lang="en">Ravnskov U. Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism. Br J Clin Pharmacol 1999; 47(2):203-210. PMID: 10190656</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Холопов АП, Шашель ВА, Перов ЮМ, Настенко ВП. Грязелечение. Периодика Кубани, Краснодар., 2003; 283</mixed-citation><mixed-citation xml:lang="en">Kho-lopov AP, Shashel' VA, Perov YuM, Nastenko VP. Mud Treatment. Periodika Kubani, Krasnodar., 2003; 283</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Пономаренко ГН, ред. Физическая и реабилитационная медицина: национальное руководство. ГЭОТАР-Медиа, М., 2016; 688</mixed-citation><mixed-citation xml:lang="en">Ponomarenko GN, red.. Fizicheskaya i reabilitatsion-naya meditsina: natsional'noe rukovodstvo. GEOTAR-Media, M., 2016; 688</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Поддубная ОА. Синусоидальные модулированные токи в клинической физиотерапии. Физиотерапия, бальнеология и реабилитация 2017;16(1):39-47</mixed-citation><mixed-citation xml:lang="en">Poddubnaya OA. Sinusoidal'nye modulirovannye toki v klinicheskoy fizioterapii. Fizioterapiya, bal'neologiya i reabilitatsiya 2017;16(1):39-47</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Самосюк ИЗ, Евтушенко СК, Самосюк НИ. Основные принципы выбора зон воздействия и их обоснование при использовании физических факторов в медицинской реабилитации. Международный неврологический журнал 2012; 8(54):112-122</mixed-citation><mixed-citation xml:lang="en">Samosyuk IZ, Yevtushenko SK, Samo-syuk NI. basic principles for selection of treatment zones and their rationale for use of physical factors in medical rehabilitation. International neurological journal 2012; 8(54):112-122</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
